Aier Eye Hospital Group Co., Ltd. (SZSE:300015) signed a purchase agreement to acquire Tianjin Zhongshixin Enterprise Management Co., Ltd. from Panxin (Shanghai) Investment Center (Limited Partnership) and Panmao (Shanghai) Investment Center (Limited Partnership) for CNY 1.8 billion on October 29, 2019 Under the terms, Aier Eye will issue 22.9 million shares each to Panxin (Shanghai) Investment Center (Limited Partnership) and Panmao (Shanghai) Investment Center (Limited Partnership) as consideration. In related transactions, Aier Eye Hospital Group will acquire 100% stake in Zhanjiang Allad Visual Optics Center Co., Ltd. and 80% stake in Xuancheng Eye Hospital Co., Ltd. from Guangdong Zhongsheng Pharmaceutical Co., Ltd. for a cash and stock consideration, and 90% stake each in Chongqing Wanzhou Every Sunshine Eye Hospital and Chongqing Kaizhou Every Sunshine Eye Hospital Co., Ltd from Li Mahao, Shang Yali and Weifang Mule Enterprise Management Consulting Partnership (Limited Partnership) for a stock consideration on October 29, 2019. As of September 30, 2019, Tianjin Zhongshixin Enterprise Management Co., Ltd had total assets of CNY 801.67 million and equity of CNY 506.35 million. On October 29, 2019, Aier Eye Hospital Group approved the transaction at the 53rd meeting of the fourth session of the Board of Directors, and reviewed and passed relevant proposals. On October 29, 2019, Panxin (Shanghai) Investment’s Executive Partner Shanghai Panxin Mezzanine Investment Management Co., Ltd. made a decision and agreed to the signing of the purchase agreement. On January 7, 2020, Shanghai PanXin Mezzanine Investment Management Co., Ltd. made a decision and agreed to the present transfer. On October 29, 2019, Shanghai Pannuo Enterprise Management Service Co., Ltd., the executive partner of Panmao (Shanghai) Investment, made a decision and agreed to the signing of the purchase agreement. On January 7, 2020, Shanghai Pannuo Enterprise Management Service Co., Ltd., made a decision and agreed to the signing of a supplementary agreement to the present transfer. On January 7, 2020, Aier Eye Hospital Group approved the transaction at the third meeting of the fifth session of the Board of Directors. On February 3, 2020, Aier Eye Hospital Group’s extraordinary general meeting of shareholders approved the proposals concerning the transactions. On April 23, 2020, the China Securities Regulatory Commission's listed company merger and reorganization audit committee conditionally approved the matters concerning the issuance of shares and the payment of cash to purchase assets and the collection of supporting funds. Huatai United Securities Co., Ltd. acted as financial advisor and Hunan Qiyuan Law Firm acted as legal advisor to Aier Eye Hospital. Mazars China Certified Public Accountants (Special General Partnership) acted as accountant to Aier Eye Hospital and Tianjin Zhongshixin Enterprise. Hubei Zhonglian Asset Evaluation Co., Ltd. acted as evaluation agency of transaction subject for Aier Eye Hospital.